PEPD is a pivotal regulator of p53 tumor suppressor

被引:24
|
作者
Yang, Lu [1 ]
Li, Yun [1 ,2 ]
Bhattacharya, Arup [1 ]
Zhang, Yuesheng [1 ,3 ]
机构
[1] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA
来源
NATURE COMMUNICATIONS | 2017年 / 8卷
关键词
PROTEIN-PROTEIN INTERACTION; GROWTH-FACTOR RECEPTOR; PROLINE-RICH DOMAIN; PROLIDASE DEFICIENCY; SH3; DOMAIN; EXPRESSION; APOPTOSIS; ENZYME; TRANSACTIVATION; CHEMOTHERAPY;
D O I
10.1038/s41467-017-02097-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
p53 tumor suppressor responds to various cellular stresses and regulates cell fate. Here, we show that peptidase D (PEPD) binds and suppresses over half of nuclear and cytoplasmic p53 under normal conditions, independent of its enzymatic activity. Eliminating PEPD causes cell death and tumor regression due to p53 activation. PEPD binds to the proline-rich domain in p53, which inhibits phosphorylation of nuclear p53 and MDM2-mediated mitochondrial translocation of nuclear and cytoplasmic p53. However, the PEPD-p53 complex is critical for p53 response to stress, as stress signals doxorubicin and H2O2 each must free p53 from PEPD in order to achieve robust p53 activation, which is mediated by reactive oxygen species. Thus, PEPD stores p53 for the stress response, but this also renders cells dependent on PEPD for survival, as it suppresses p53. This finding provides further understanding of p53 regulation and may have significant implications for the treatment of cancer and other diseases.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Enigmas of p53 tumor suppressor gene
    Belousova, AK
    EXPERIMENTAL ONCOLOGY, 1996, 18 (03): : 197 - 207
  • [42] Peptide Activators of the p53 Tumor Suppressor
    Zhan, Changyou
    Lu, Wuyuan
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (06) : 603 - 609
  • [43] THE P53 TUMOR SUPPRESSOR GENE AND PRODUCT
    LEVINE, AJ
    CANCER SURVEYS, 1992, 12 : 59 - 79
  • [44] Guardian of the Genome: p53 Tumor Suppressor
    Lubkeman, Kelly
    Palacio, Megan
    Wedel, Greta
    Delacruz, Kimy Hernandez
    Nguyen, Selina
    Alcaraz-Soto, Sheccid
    Szerdy, Sydney
    Fuentez, Tori
    Nunez, Oliver
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S689 - S689
  • [45] Molecular Architecture of Tumor Suppressor p53
    Viadiu, Hector
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (15) : 1327 - 1334
  • [46] The role of the tumor suppressor p53 in spermatogenesis
    Beumer, TL
    Roepers-Gajadien, HL
    Gademan, IS
    van Buul, PPW
    Gil-Gomez, G
    Rutgers, DH
    de Rooij, DG
    CELL DEATH AND DIFFERENTIATION, 1998, 5 (08): : 669 - 677
  • [47] p53 tumor suppressor and iron homeostasis
    Zhang, Jin
    Chen, Xinbin
    FEBS JOURNAL, 2019, 286 (04) : 620 - 629
  • [48] Regulators and mediators of the p53 tumor suppressor
    Cadwell, C
    Zambetti, GP
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1998, : 43 - 49
  • [49] Tumor suppressor p53 meets microRNAs
    Feng, Zhaohui
    Zhang, Cen
    Wu, Rui
    Hu, Wenwei
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2011, 3 (01) : 44 - 50
  • [50] The tumor suppressor p53 - Cancer and aging
    Feng, Zhaohui
    Hu, Wenwei
    Rajagopal, Gunaretnam
    Levine, Arnold J.
    CELL CYCLE, 2008, 7 (07) : 842 - 847